Acrivon Therapeutics Inc

ACRVNASDAQ · US

Holders

REDUCEDT+7
Miller Mary
Acrivon Therapeutics Inc · NASDAQ
−294 sh · $585
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDStale
Levin Michaela
Acrivon Therapeutics Inc · NASDAQ
+30,000 sh
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Blume-Jensen Peter
Acrivon Therapeutics Inc · NASDAQ
−14,036 sh · $31.0K
Filed 27 Aug 2026SEC Form 4view source
REDUCEDStale
Peterson Katharine
Acrivon Therapeutics Inc · NASDAQ
−101 sh · $203
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Blume-Jensen Peter
Acrivon Therapeutics Inc · NASDAQ
−1,229 sh · $2.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Gamelin Erick
Acrivon Therapeutics Inc · NASDAQ
−400 sh · $804
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Devroe Eric
Acrivon Therapeutics Inc · NASDAQ
−604 sh · $1.2K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Miller Mary
Acrivon Therapeutics Inc · NASDAQ
−185 sh · $372
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Blume-Jensen Peter
Acrivon Therapeutics Inc · NASDAQ
−484 sh · $973
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Acrivon Therapeutics Inc · NASDAQ
389,395 sh · $541.3K
Filed 31 Mar 2026SEC 13Fview source